Inventor · disambiguated record
Mark Alderson
Also filed as: ALDERSON MARK · ALDERSON MARK R · ALDERSON MARK RAYMOND
28 granted patents·8 pending applications·1,020 citations·filing 1993–2014
97Inventor score
Top patents by PatentIndex Score
36 records- 0197US7335369B2Fusion proteins of mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 2006·Granted Feb 26, 2008·26 cites·15 claims
- 0297US7261897B2Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2006·Granted Aug 28, 2007·56 cites·13 claims
- 0396US6355779B1Cytokine designated 4-1BB ligand antibodies and human receptor that binds theretoIMMUNEX CORP·Filed 1998·Granted Mar 12, 2002·166 cites·4 claims
- 0494US7083796B2Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2001·Granted Aug 1, 2006·36 cites·28 claims
- 0593US6977069B2Fusion proteins of Mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 2003·Granted Dec 20, 2005·27 cites·9 claims
- 0693US5674704ACytokine designated 4-IBB ligandIMMUNEX CORP·Filed 1994·Granted Oct 7, 1997·123 cites·20 claims
- 0792US6555653B2Compounds for diagnosis of tuberculosis and methods for their useCORIXA CORP·Filed 1998·Granted Apr 29, 2003·87 cites·13 claims
- 0891US7186412B1Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2000·Granted Mar 6, 2007·38 cites·27 claims
- 0990US6627198B2Fusion proteins of Mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 1999·Granted Sep 30, 2003·64 cites·9 claims
- 1089US7138500B1Antibodies to human 4-1BBIMMUNEX CORP·Filed 1998·Granted Nov 21, 2006·50 cites·6 claims
- 1188US7064195B2Fusion proteins of mycobacterium tuberculosis antigens and their usesCORIXA·Filed 2003·Granted Jun 20, 2006·28 cites·9 claims
- 1288US5801227AAntibodies to CD40Filed 1995·Granted Sep 1, 1998·99 cites·6 claims
- 1386US8071747B2Fusion proteins of mycobacterium tuberculosisSKEIKY YASIR·Filed 2009·Granted Dec 6, 2011·4 cites·48 claims
- 1486US6544522B1Fusion proteins of mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 1998·Granted Apr 8, 2003·54 cites·8 claims
- 1584US6613881B1Compounds for immunotherapy and diagnosis of tuberculosis and methods of their useCORIXA CORP·Filed 1998·Granted Sep 2, 2003·54 cites·13 claims
- 1683US8143386B2Fusion proteins of mycobacterium tuberculosis antigens and their usesREED STEVEN G·Filed 2007·Granted Mar 27, 2012·6 cites·23 claims
- 1778US8541007B2Vaccines against chlamydial infectionALDERSON MARK·Filed 2010·Granted Sep 24, 2013·5 cites·14 claims
- 1869US7976844B2Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2006·Granted Jul 12, 2011·0 cites·29 claims
- 1969US5830469AFas antagonists and uses thereofIMMUNEX CORP·Filed 1995·Granted Nov 3, 1998·24 cites·28 claims
- 2066US2006034764A1Fusion proteins of mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 2005·Application pending·0 cites
- 2165US7973153B2Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2007·Granted Jul 5, 2011·0 cites·28 claims
- 2256US2006110802A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2003·Application pending·0 cites
- 2354US5620889AHuman anti-Fas IgG1 monoclonal antibodiesIMMUNEX CORP·Filed 1994·Granted Apr 15, 1997·18 cites·25 claims
- 2452US5726286AIsolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chainsIMMUNEX CORP·Filed 1995·Granted Mar 10, 1998·13 cites·2 claims
- 2552US2015079132A1Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantlyPATH·Filed 2014·Application pending·0 cites
- 2652US2010172927A1Vaccines Against Chlamydial InfectionALDERSON MARK·Filed 2007·Application pending·0 cites
- 2751US5474769ATreatment of microbial infection by monocyte stimulation with interleukin-7STERLING WINTHROP INC·Filed 1993·Granted Dec 12, 1995·12 cites·16 claims
- 2851US2009022755A1Vaccines against chlamydial infectionGLAXOSMITHKLINE BIOLOG SA·Filed 2006·Application pending·0 cites
- 2950US5925734AIsolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchainsIMMUNEX CORP·Filed 1997·Granted Jul 20, 1999·5 cites·6 claims
- 3049US2006127985A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2005·Application pending·0 cites
- 3147US6015559AFas antagonistsIMMUNEX CORP·Filed 1998·Granted Jan 18, 2000·9 cites·17 claims
- 3246US5716623AIsolated Herpesvirus saimiri proteins that bind MHC Class II moleculesIMMUNEX CORP·Filed 1995·Granted Feb 10, 1998·11 cites·10 claims
- 3343US2014056967A1Vaccines against chlamydial infectionCORIXA CORP·Filed 2013·Application pending·0 cites
- 3442US5681557AUse of interleukin-7 to induce monocytes/macrophages cytotoxic activitySTERLING WINTHROP INC·Filed 1995·Granted Oct 28, 1997·5 cites·3 claims
- 3534US9827299B2Selectively disrupted whole-cell vaccineMALLEY RICHARD·Filed 2010·Granted Nov 28, 2017·0 cites·4 claims
- 3630US2002081579A1Method for the isolation of novel antigensJANE E R POTTER·Filed 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Alderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →